12 results - M - W - D

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/18/23 17:46
10/16/23
SRRKHealthBioPrdBiological Products, (No DiagAkkaraju SrinivasCADTP15,0006.8502,190486,789I
10/18/23 17:44
10/16/23
SRRKHealthBioPrdBiological Products, (No DiagSamsara Biocapital Gp, LLCCATP15,0006.8502,190486,789I
10/16/23 17:46
10/12/23
SRRKHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP15,0876.8602,2002411,259D
5/2/23 21:00
4/28/23
SRRKHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP2036.4303209,060D
1/9/23 17:22
1/5/23
SRRKHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP4559.3304919,029D
10/27/22 16:36
10/25/22
SRRKHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP1,0478.04013018,980D
10/7/22 16:30
10/3/22
SRRKHealthBioPrdBiological Products, (No DiagInvus Public Equities, L.P.NYTP.m7607.60010018,850D
6/24/22 16:27
6/22/22
SRRKHealthBioPrdBiological Products, (No DiagNashat AmirMADP.d5,8704.9001,198214I
5/31/18 21:43
5/29/18
SRRKHealthBioPrdBiological Products, (No DiagPolaris Venture Management Co. Vi, L.L.C.MATP.d2,00014.00014352,833I
5/31/18 21:42
5/29/18
SRRKHealthBioPrdBiological Products, (No DiagNashat AmirMADTP.d2,00014.00014352,833I
5/31/18 21:41
5/29/18
SRRKHealthBioPrdBiological Products, (No DiagArtal International S.C.A.N4TP.d6,30014.000450232,396M
5/31/18 21:41
5/29/18
SRRKHealthBioPrdBiological Products, (No DiagSpringer Timothy AMADTP.d1,00014.0007123,549M

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact